EDIT
Editas Medicine Inc
NASDAQ: EDIT · HEALTHCARE · BIOTECHNOLOGY
$2.82
-7.84% today
Updated 2026-04-29
Market cap
$284.81M
P/E ratio
—
P/S ratio
7.03x
EPS (TTM)
$-1.80
Dividend yield
—
52W range
$1 – $5
Volume
1.7M
Editas Medicine Inc (EDIT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-2.78M | $-8.65M | $-5.40M | $-49.93M | $-9.42M | $-45.71M | $-40.67M | $-179.84M | $-163.80M | $-177.35M | $-132.18M | $-210.28M | $-165.24M |
| Capital expenditures | $159000.00 | $1.22M | $1.43M | $3.49M | $2.06M | $4.75M | $6.17M | $7.16M | $7.98M | $4.12M | $4.72M | $8.83M | $607000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $60000.00 | $55000.00 | $3.51M | $16.88M | $23.36M | $26.60M | $27.24M | $23.16M | $43.40M | $29.29M | $19.80M | $21.42M | $10.00M |
| Free cash flow | $-2.94M | $-9.87M | $-6.83M | $-53.42M | $-11.48M | $-50.46M | $-46.84M | $-187.00M | $-171.78M | $-181.47M | $-136.90M | $-219.11M | $-165.85M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $143.19M | $782000.00 | $11000.00 | $4000.00 | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $42.14M | $-38.69M | $-11.85M | $103.41M | $-96.24M | $63.84M | $-62.00M | — | — | — |